ConcertAI, Janssen expand data science partnership

By The Science Advisory Board staff writers

August 25, 2021 -- ConcertAI has expanded its multiyear collaboration with Janssen Research and Development to develop new therapies while addressing health disparities in clinical trials.

The partnership aims to develop more effective treatments for patients using ConcertAI's oncology real-world data and artificial intelligence (AI). Through the partnership, ConcertAI will broaden the sources of data used, moving earlier into disease states and assuring that more patients have access to therapies both through clinical trials and through enhanced evidence generation.

Copyright © 2021

Create an Account

Already have an account? Sign in Here

To access all ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for

Email Preferences

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.